LAUSR

247Background: Health insurance disparities affect the treatment and outcomes of many cancers and include differences in screening, surgical therapy and receipt of adjuvant therapy. The purpose of this study is to better identify the effect of health insurance on surgical therapy and overall survival (OS) in pancreatic adenocarcinoma (PDAC). Methods: 4564 patients diagnosed with PDAC between 2004 and 2013 from the Tennessee Cancer Registry were stratified into 5 groups: Private, Medicare, Military, Medicaid, and uninsured. Univariate analysis and multivariable (MV) logistic regression models were used to test the association of insurance with receipt of surgical therapy, adjuvant therapy, OS and cost. Results: Uninsured and Medicaid patients were more often black and presented with later stage disease. In patients with stage 1 and 2 disease, R0 resection rates, lymph node positivity and overall cost were similar across insurance groups. By MV analysis, Medicare and Military insurance patients were more li...